Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 1)

GRANT OF SHARE OPTIONS BY HUTCHISON CHINA MEDITECH LIMITED

This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").

The board of directors (the "Board") of CK Hutchison Holdings Limited (the "Company") announces that on 27 March 2017, 150,000 share options were granted by Hutchison China MediTech Limited ("HCML", an approximately 60.39% held subsidiary of the Company, whose shares are traded on the AIM market of the London Stock Exchange and in the form of American Depositary Shares on the NASDAQ Stock Market) under its share option scheme (the "HCML Scheme", which was unconditionally adopted on 13 May 2016) to certain Eligible Employees (as defined in the HCML Scheme) (the "Grantees") to subscribe for ordinary shares of nominal value of US$1 each of HCML (each a "HCML Share"). Details of such share options are as follows:

Date of grant

:

27 March 2017

Exercise price of share options granted

:

GBP31.05 per HCML Share

Number of share options granted

:

150,000 (each share option shall entitle the holders thereof to subscribe for one HCML Share)

Closing market price of the HCML Shares on the date of grant

:

GBP31.05 per HCML Share

Validity period of the share options

:

from 27 March 2017 to 26 March

2027

100,000 out of the 150,000 share options were granted to Dr Weiguo Su, Executive Director and Chief Scientific Officer of HCML. Save as disclosed above, none of the Grantees is a director, chief executive nor substantial shareholder of HCML, or an associate (as defined under the Listing Rules) of any of them.

By Order of the Board

Edith Shih

Executive Director and Company Secretary

Hong Kong, 28 March 2017

As at the date of this announcement, the Directors of the Company are:

Executive Directors:

Mr LI Ka-shing (Chairman)

Mr LI Tzar Kuoi, Victor (Group Co-Managing Director and Deputy Chairman)

Mr FOK Kin Ning, Canning

(Group Co-Managing Director)

Mr Frank John SIXT (Group Finance Director and Deputy Managing Director)

Mr IP Tak Chuen, Edmond

(Deputy Managing Director)

Mr KAM Hing Lam

(Deputy Managing Director)

Mr LAI Kai Ming, Dominic

(Deputy Managing Director)

Ms Edith SHIH

Non-executive Directors:

Mr CHOW Kun Chee, Roland

Mrs CHOW WOO Mo Fong, Susan Mr LEE Yeh Kwong, Charles

Mr LEUNG Siu Hon

Mr George Colin MAGNUS

Independent Non-executive Directors:

Mr KWOK Tun-li, Stanley

Mr CHENG Hoi Chuen, Vincent

The Hon Sir Michael David KADOORIE Ms LEE Wai Mun, Rose

Mr William Elkin MOCATTA (Alternate to The Hon Sir Michael David Kadoorie)

Mr William SHURNIAK Mr WONG Chung Hin

Dr WONG Yick-ming, Rosanna

CK Hutchison Holdings Limited published this content on 28 March 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 28 March 2017 10:10:16 UTC.

Original documenthttp://www.irasia.com/listco/hk/ckh/announcement/a172214-e_announcement.pdf

Public permalinkhttp://www.publicnow.com/view/DBD9E7FA54F2FA6AC4F740FD95F3CB53FF8141D1